Live Breaking News & Updates on Sumitomo Pharma America Inc

Stay updated with breaking news from Sumitomo pharma america inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lynch Carpenter Investigates Claims in Cencora, Inc. Data

PITTSBURGH, May 29, 2024 (GLOBE NEWSWIRE) Cencora, Inc. recently announced that it suffered from a cybersecurity attack that occurred in February of. ....

United States , Patrick Donathen , Cencora Inc , Lynch Carpenter , Endo Pharmaceuticals Inc , Sumitomo Pharma America Inc , Abbvie Inc , Acadia Pharmaceuticals Inc , Glaxosmithkline Group , Bayer Corporation , Novartis Pharmaceuticals Corporation , Regeneron Pharmaceuticals Inc , Genetech Inc Incyte Corporation , Dendreon Pharmaceuticals , Genetech Inc , Incyte Corporation , Sumitomo Pharma America ,

Major Pharma Companies Affected by Cencora Data Breach

More than a dozen pharmaceutical companies have been affected by the Cencora cyberattack and data breach that occurred in February. ....

United States , Regeneron Pharmaceuticals Inc , Acadia Pharmaceuticals Inc , Genentech Inc , Marathon Pharmaceuticals , Dendreon Pharmaceuticals , Bayer Corporation , Endo Pharmaceuticals Inc , Exchange Commission , Pharming Healthcare Inc , Bristol Myers Squibb Company , Sunovion Pharmaceuticals Inc , Glaxosmithkline Group Of Companies , Novartis Pharmaceuticals Corporation , Abbvie Inc , Bristol Myers Squibb Patient Assistance Foundation , Glaxosmithkline Patient Access Programs Foundation , Therapeutics Inc , Sumitomo Pharma America Inc , Incyte Corporation , Myers Squibb Company , Bristol Myers Squibb Patient Assistance , Smithkline Group , Glaxosmithkline Patient Access Programs , Pharma America , Sunovion Pharmaceuticals ,

Sumitomo Pharma America Announces Data Breach, Possibility Related to Incident at Cencora | Console and Associates, P.C.

On May 24, 2024, Sumitomo Pharma America, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been provided to. ....

United States , Sumitomo Pharma America , More Information About Sumitomo Pharma America Inc , Sumitomo Pharma America Inc , Sumitomo Pharma Co Ltd , Attorney General , Sumitomo Pharma America Data , Information About Sumitomo Pharma America , Pharma America ,

Vibegron Under Review for Men With OAB Symptoms Receiving BPH Treatment

The FDA has accepted the sNDA for vibegron for the treatment of men with overactive bladder symptoms receiving drug therapy for BPH. ....

Tsutomu Nakagawa , Sumitomo Pharma America Inc , International Prostate Symptoms Storage , Drug Administration , New Drug Application , Sumitomo Pharma America ,

Sumitomo Pharma : Posted Conference on FY2023 Financial Results

May 14, 2024

Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including. ....

Toru Kimura , Tsutomu Nakagawa , Hisayoshi Kashima , Motoyuki Sakaibirthdate , Hiroshi Niinuma , Takashi Kutsunai , Minoru Usui , Motoyuki Sakai , Yoshio Iteya , Saeko Arai , Nobuhiro Endo , Mayumi Mochizuki , Koji Fujimoto , Daishiro Michimori , Hiroshi Nomura , School Of Science , Sumitomo Pharma America Inc , Senior Executive Research , Chemical Co Ltd , Kyoto University , Regenerative Cellular Medicine Office , Corporate Communications , Affairs Dept , Co Ltd , Sumitomo Pharmaceuticals Co Ltd , Sumitomo Chemical Co Ltd ,